Paper Details
- Home
- Paper Details
Molecular basis of hypertension side effects induced by sunitinib.
Author: Afonso-AfonsoFrancisco J, Antón-AparicioLuis M, Aparicio-GallegoGuadalupe, Campos-BaleaBegoña, Fernández-CalvoOvidio, Fírvida-PérezJose L, León-MateosLuis, Lázaro-QuintelaMartín, Ramos-VázquezManuel, Vázquez-EstévezSergio
Original Abstract of the Article :
Over the past decade a number of vascular complications have emerged, such as newly developed or worsened hypertension, in patients who were administered with new cancer treatments for several types of cancer that were untreatable earlier. Hypertension is emerging as one of the most common adverse e...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1097/CAD.0b013e3283403806
データ提供:米国国立医学図書館(NLM)
The Curious Case of Sunitinib and Hypertension
This study explores the unexpected connection between sunitinib, a targeted cancer therapy, and hypertension. The researchers, like skilled medical detectives, are investigating the mechanisms by which this drug can cause or worsen high blood pressure in cancer patients. They delve into the intricate world of vascular function and angiogenesis, seeking to understand the interplay between sunitinib and the cardiovascular system.
Unveiling the Hidden Side Effects of Cancer Therapies
This study highlights the importance of understanding the potential side effects of cancer therapies, even those that are specifically targeted to kill cancer cells. It underscores the need for careful monitoring and management of blood pressure in patients receiving sunitinib and other angiogenesis inhibitors. This is like uncovering a hidden oasis in the vast desert of cancer therapy, revealing a potentially dangerous side effect that requires attention and management.
Navigating the Desert of Cancer Treatment
This study provides valuable guidance for healthcare providers treating cancer patients with sunitinib and other angiogenesis inhibitors. It emphasizes the importance of carefully monitoring blood pressure and taking steps to manage hypertension, ensuring the best possible outcomes for these patients. This is like finding a safe path through the treacherous desert of cancer treatment, guiding patients and providers towards a successful journey.
Dr. Camel's Conclusion
This study sheds light on the complex relationship between cancer therapies and cardiovascular health. It underscores the importance of vigilant monitoring and proactive management of hypertension in patients receiving sunitinib and other angiogenesis inhibitors. It's like finding a new trail in the desert of cancer treatment, offering a path towards a more effective and safer journey for patients.
Date :
- Date Completed 2011-03-04
- Date Revised 2022-03-17
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.